Minimally Invasive Treatment of Trapeziometacarpal Osteoarthritis
Minimally Invasive Treatment of Trapeziometacarpal Osteoarthritis
Minimally Invasive Treatment of Trapeziometacarpal Osteoarthritis: Results of a Blinded Randomized Controlled Trial.
Plast Reconstr Surg . 2023 Dec 1;152(6):1277-1285.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Ninety-five patients with carpometacarpal arthritis were randomized to receive autologous fat (n=25), platelet-rich plasma (PRP; n=24), autologous fat and PRP (n=25), or 0.9% saline solution (n=21). The primary outcome of interest was pain reduction. Secondary outcomes included improvements in hand function (QuickDASH score), quality of life (SF-36 score), range of motion, pinch, and power grip. O...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.